FDA vaccine advisers vote to recommend booster doses of Covid-19 vaccine in people 65 and older and those at high risk
Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer’s vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19.
Continue Reading